Archive: 26/02/2015
A novel immunotherapy technique to treat patients with osteosarcoma and neuroblastoma
A novel phase 1 clinical trial that leverages T-cell immunotherapy is now under way at Karmanos Cancer Institute (KCI) in Detroit and Memorial Sloan-Kettering Cancer Center in New York City; bringing new hope to children ...
Feb 26, 2015
Minipool technology to prepare immunoglobulins to fight viral infections in developing countries
A study publishing February 26th, 2015 in PLOS Neglected Tropical Diseases describes a new, pragmatic, method for the production of immunoglobulin G (IgG) from human plasma in developing countries. IgG are therapeutic preparations ...
Feb 26, 2015
People with disabilities experience unrecognized health disparities, new research shows
People with disabilities have unmet medical needs and poorer overall health throughout their lives, and as a result should be recognized as a health disparity group so more attention can be directed to improving their quality ...
Feb 26, 2015
Researchers reverse type 2 diabetes and fatty liver disease in rats
Yale researchers developed a controlled-release oral therapy that reversed type 2 diabetes and fatty liver disease in rats, according to a study published on Feb. 26 by Science.
Feb 26, 2015